📋 Course Outline
- Glucose Transporters (GLUTs)
- Glucose Phosphorylation Enzymes
- Glycolysis Regulation
- Glycolytic Intermediates
- Pyruvate Fate
- Glycerol Metabolism
- Fructose Metabolism
- Pentose Phosphate Pathway
📖 1. Glucose Transporters (GLUTs)
🔑 Key Concepts & Definitions
- Glucose Transporters (GLUTs): A family of facilitated diffusion proteins that mediate the transport of glucose across cell membranes without requiring ATP.
- Facilitated Diffusion: A passive transport mechanism where molecules move along their concentration gradient via specific carrier proteins like GLUTs.
- Isoforms of GLUT: Different GLUT proteins (e.g., GLUT1-14) with tissue-specific expression and varying affinities for glucose.
- Km (Michaelis constant): The substrate concentration at which the transporter operates at half its maximum rate; indicates affinity (low Km = high affinity).
- Insulin-regulated GLUT4: A GLUT isoform in muscle and adipose tissue that translocates to the cell membrane in response to insulin, increasing glucose uptake.
- Glucose Sensor: A GLUT (notably GLUT2) that detects blood glucose levels and helps regulate metabolic responses.
📝 Essential Points
- Transport Mechanism: GLUTs facilitate glucose entry into cells down its concentration gradient; no ATP is directly involved.
- Tissue-specific Expression:
- GLUT1: Ubiquitous, high in blood-brain barrier and erythrocytes; low Km, high affinity.
- GLUT2: Liver, pancreas, small intestine; high Km, acts as a glucose sensor.
- GLUT3: Neurons and placenta; high affinity for glucose.
- GLUT4: Muscle and adipose tissue; insulin-dependent, low Km.
- Regulation of GLUT4: Insulin triggers translocation of GLUT4 vesicles to the plasma membrane, increasing glucose uptake, especially during exercise.
- Significance of Km: Determines tissue responsiveness to blood glucose levels; high affinity (low Km) tissues can uptake glucose efficiently even at low blood glucose concentrations.
- Glucose Sensor: GLUT2’s high Km allows it to respond to changes in blood glucose, regulating insulin secretion and hepatic glucose handling.
💡 Key Takeaway
Glucose transport into cells is primarily mediated by specific GLUT isoforms, with their tissue-specific expression and regulation ensuring proper glucose homeostasis, notably through insulin-dependent GLUT4 translocation in muscle and adipose tissue and GLUT2’s role as a glucose sensor in the liver and pancreas.
📖 2. Glucose Phosphorylation Enzymes
🔑 Key Concepts & Definitions
-
Hexokinase: An enzyme that catalyzes the phosphorylation of glucose to glucose-6-phosphate (G6P) in most tissues; has a low Km indicating high affinity for glucose and is feedback-inhibited by G6P.
-
Glucokinase: A liver and pancreatic enzyme that also phosphorylates glucose to G6P; characterized by a high Km, no feedback inhibition, and acts as a glucose sensor responding to blood glucose levels.
-
Phosphorylation: The addition of a phosphate group to a molecule; in glycolysis, it traps glucose inside cells and primes it for subsequent metabolism.
-
Km (Michaelis constant): The substrate concentration at which an enzyme operates at half its maximum velocity; indicates enzyme affinity for substrate.
-
Feedback inhibition: A regulatory mechanism where the product of a pathway inhibits an earlier enzyme, controlling pathway flux (e.g., G6P inhibits hexokinase).
-
GKRP (Glucokinase Regulatory Protein): A protein that binds glucokinase in the nucleus in low glucose conditions, regulating its activity and localization.
📝 Essential Points
-
Glucose phosphorylation is the first committed step in glycolysis, preventing glucose from diffusing out of the cell.
-
Hexokinase is ubiquitous, with high affinity for glucose, but its activity is limited by feedback inhibition from G6P.
-
Glucokinase is primarily in liver and pancreatic β-cells; it has a high Km, meaning it is active only at higher glucose concentrations, making it suitable for glucose sensing.
-
Regulation of glucokinase involves its interaction with GKRP, which sequesters it in the nucleus at low glucose levels; high glucose causes dissociation, activating glucokinase.
-
Enzymes involved in phosphorylation:
- Hexokinase (all tissues, low Km, feedback-inhibited)
- Glucokinase (liver, pancreas, high Km, no feedback inhibition)
-
Physiological significance:
- Hexokinase maintains basal glucose phosphorylation.
- Glucokinase responds to post-meal glucose surges, regulating glycogen synthesis in the liver and insulin secretion in pancreas.
💡 Key Takeaway
Hexokinase and glucokinase both catalyze glucose phosphorylation but differ in tissue distribution, affinity for glucose, and regulatory mechanisms; glucokinase acts as a glucose sensor in the liver and pancreas, adapting glucose metabolism to blood levels.
📖 3. Glycolysis Regulation
🔑 Key Concepts & Definitions
- Glycolysis: A metabolic pathway that converts glucose into pyruvate, generating ATP and NADH in the process.
- Hexokinase: An enzyme that phosphorylates glucose to glucose-6-phosphate (G6P), present in most tissues; sensitive to feedback inhibition by G6P.
- Glucokinase: A liver and pancreatic enzyme with high Km for glucose, less sensitive to feedback inhibition, acting as a glucose sensor.
- Phosphofructokinase-1 (PFK1): The rate-limiting enzyme of glycolysis that catalyzes the phosphorylation of fructose-6-phosphate; allosterically regulated.
- Allosteric Regulation: Modulation of enzyme activity through binding of effectors at sites other than the active site, e.g., ATP, ADP, citrate, fructose-2,6-bisphosphate.
- Substrate-Level Phosphorylation: Direct synthesis of ATP from ADP during glycolysis, notably in steps catalyzed by phosphoglycerate kinase and pyruvate kinase.
📝 Essential Points
- Regulation of Glucose Phosphorylation:
- Hexokinase is inhibited by G6P, preventing excess accumulation.
- Glucokinase in the liver responds to high glucose levels, with activity regulated by glucokinase regulatory protein (GKRP) which sequesters it in the nucleus at low glucose.
- PFK1 Regulation:
- Activated by high AMP/ADP and fructose-2,6-bisphosphate (F2,6P).
- Inhibited by high ATP, citrate, and H+ ions (acidic pH).
- F2,6P is produced by PFK2, a bifunctional enzyme regulated hormonally: stimulated by insulin (promoting glycolysis), inhibited by glucagon.
- Metabolic Control Points:
- The first irreversible step is catalyzed by hexokinase/glucokinase.
- The third step, catalyzed by PFK1, is the key regulatory and rate-limiting step.
- Interaction with Other Pathways:
- Glycerol from triglycerides and fructose can feed into glycolysis at various points.
- NADH produced in glycolysis is reoxidized to NAD+ via lactate formation under anaerobic conditions or through mitochondrial respiration aerobically.
- Energy Yield:
- Net gain of 2 ATP per glucose molecule via substrate-level phosphorylation.
- Production of 2 NADH molecules, which can generate additional ATP in the electron transport chain.
💡 Key Takeaway
Glycolysis is tightly regulated at key enzymatic steps—particularly by phosphofructokinase-1—allowing cells to adapt energy production to metabolic needs and substrate availability, with regulation influenced by hormonal signals and cellular energy status.
🔑 Key Concepts & Definitions
- Glycolysis: A metabolic pathway that converts glucose into pyruvate, producing ATP and NADH through a series of ten enzymatic reactions.
- Glucose-6-phosphate (G6P): The phosphorylated form of glucose formed by hexokinase or glucokinase, trapping glucose inside cells and serving as a metabolic hub.
- Hexokinase: An enzyme that catalyzes the phosphorylation of glucose to G6P, active in most tissues, sensitive to feedback inhibition by G6P.
- Glucokinase: A liver and pancreatic enzyme with high Km for glucose, less sensitive to feedback inhibition, acting as a glucose sensor.
- Phosphofructokinase-1 (PFK1): The rate-limiting enzyme of glycolysis that catalyzes the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate, regulated allosterically by energy status signals.
- Substrate-level phosphorylation: The direct synthesis of ATP from ADP during glycolysis, notably in steps catalyzed by phosphoglycerate kinase and pyruvate kinase.
📝 Essential Points
- Glycolysis Overview: Consists of an energy investment phase (first 5 steps) consuming 2 ATP, and an energy payoff phase (last 5 steps) generating 4 ATP, resulting in a net gain of 2 ATP per glucose.
- Key Regulatory Step: Step 3, catalyzed by PFK1, is the primary control point, sensitive to cellular energy levels (AMP, ADP, ATP, citrate, and fructose 2,6-bisphosphate).
- Glucose Phosphorylation: Initiated by hexokinase in most tissues or glucokinase in the liver; glucokinase acts as a glucose sensor and is less inhibited by G6P.
- Metabolic Fate of G6P: Can enter glycolysis, glycogen synthesis, the pentose phosphate pathway, or be converted into other sugars.
- Glycerol and Fructose Metabolism: Glycerol is converted to dihydroxyacetone phosphate (DHAP), feeding into glycolysis; fructose can be metabolized via hexokinase or fructokinase pathways, entering at different points.
- Pyruvate Fate: Under aerobic conditions, pyruvate is converted to acetyl-CoA; under anaerobic conditions, it is reduced to lactate, regenerating NAD+.
- Interaction with Other Pathways: The pentose phosphate pathway provides NADPH and ribose sugars; glycerol and fructose metabolism integrate with glycolysis, influencing energy and biosynthesis.
💡 Key Takeaway
Glycolysis is a tightly regulated, central metabolic pathway that converts glucose into energy and biosynthetic precursors, with key control points at hexokinase/glucokinase and phosphofructokinase-1, integrating signals from cellular energy status and other metabolic pathways.
📖 5. Pyruvate Fate
🔑 Key Concepts & Definitions
- Pyruvate: The end product of glycolysis, a 3-carbon molecule that serves as a key metabolic intermediate.
- Aerobic metabolism: Process where pyruvate is converted to acetyl-CoA in the presence of oxygen, entering the Krebs cycle for further energy production.
- Anaerobic metabolism: Process where pyruvate is reduced to lactate when oxygen is scarce, regenerating NAD+ for glycolysis.
- Lactate dehydrogenase (LDH): Enzyme catalyzing the conversion of pyruvate to lactate and vice versa, crucial in anaerobic conditions.
- Cori Cycle: The metabolic pathway where lactate produced in muscles is transported to the liver, converted back to glucose via gluconeogenesis.
- Pyruvate dehydrogenase complex (PDC): Multi-enzyme complex converting pyruvate into acetyl-CoA, linking glycolysis to the Krebs cycle.
📝 Essential Points
- Fate depends on oxygen availability:
- Aerobic conditions: Pyruvate is transported into mitochondria, converted to acetyl-CoA by pyruvate dehydrogenase, and enters the Krebs cycle for ATP generation.
- Anaerobic conditions: Pyruvate is reduced to lactate by LDH, regenerating NAD+ needed for glycolysis continuation.
- Regulation of pyruvate fate:
- Pyruvate dehydrogenase activity is regulated by phosphorylation (inactive when phosphorylated) and by energy status signals.
- Lactate production is favored during hypoxia or intense exercise to sustain glycolysis.
- Cori Cycle: Lactate produced in muscles is transported via blood to the liver, where it is converted back to glucose, maintaining blood glucose levels during anaerobic activity.
- Link to other pathways:
- Pyruvate can be used for amino acid synthesis or converted into oxaloacetate for gluconeogenesis.
- Excess acetyl-CoA can lead to fatty acid synthesis if energy is abundant.
- Clinical relevance:
- Excess lactate accumulation causes lactic acidosis.
- Impaired pyruvate dehydrogenase activity is associated with metabolic disorders and mitochondrial diseases.
💡 Key Takeaway
Pyruvate acts as a metabolic crossroads, directing energy production either through aerobic oxidation in mitochondria or anaerobic reduction to lactate, depending on oxygen availability, thus maintaining cellular energy homeostasis.
🔑 Key Concepts & Definitions
- Glycerol: A three-carbon alcohol derived from triglyceride breakdown, serving as a substrate for gluconeogenesis and glycolysis.
- Glycerol Kinase: Enzyme that phosphorylates glycerol to glycerol-3-phosphate, primarily in the liver.
- Glycerol-3-Phosphate Dehydrogenase: Enzyme that oxidizes glycerol-3-phosphate to dihydroxyacetone phosphate (DHAP), producing NADH.
- Dihydroxyacetone Phosphate (DHAP): A triose phosphate that can enter glycolysis or gluconeogenesis, interconvertible with glyceraldehyde-3-phosphate.
- Triglycerides: Storage form of fats, broken down into glycerol and fatty acids; glycerol can be reused in carbohydrate metabolism.
- Link to Glycolysis: Glycerol feeds into glycolysis at the level of DHAP, bypassing initial glucose phosphorylation steps.
📝 Essential Points
- Conversion Pathway: Glycerol is phosphorylated by glycerol kinase to glycerol-3-phosphate, then oxidized by glycerol-3-phosphate dehydrogenase to DHAP, which enters glycolysis.
- Tissue Specificity: Glycerol kinase activity is mainly in the liver; other tissues lack this enzyme.
- Energy Yield: NADH produced during glycerol oxidation can contribute to ATP generation via oxidative phosphorylation.
- Metabolic Role: Glycerol serves as a substrate for gluconeogenesis during fasting or low carbohydrate states, helping maintain blood glucose.
- Link to Lipid Metabolism: Glycerol is released during lipolysis of triglycerides; its conversion to glucose links fat and carbohydrate metabolism.
- Regulation: Glycerol metabolism is influenced by hormonal signals (e.g., insulin promotes storage, glucagon promotes lipolysis).
💡 Key Takeaway
Glycerol, derived from triglyceride breakdown, is converted into dihydroxyacetone phosphate, allowing it to feed directly into glycolysis or gluconeogenesis, thus linking fat metabolism to carbohydrate energy pathways.
🔑 Key Concepts & Definitions
- Fructose: A simple six-carbon sugar (hexose) found in fruits, honey, and as part of sucrose; metabolized primarily in the liver.
- Fructokinase (Ketohexokinase): Enzyme that phosphorylates fructose to fructose-1-phosphate in the liver, initiating its metabolism.
- Aldolase B: Enzyme that cleaves fructose-1-phosphate into dihydroxyacetone phosphate (DHAP) and glyceraldehyde, feeding into glycolysis.
- Hereditary Fructose Intolerance: Genetic deficiency of aldolase B leading to accumulation of fructose-1-phosphate, causing hypoglycemia and liver damage.
- Hepatic Fructosuria: Autosomal recessive condition caused by deficiency in fructokinase, resulting in fructose accumulation in blood and urine but no symptoms.
- Pentose Phosphate Pathway (PPP): A metabolic pathway that produces NADPH and ribose-5-phosphate; fructose metabolism can supply intermediates for this pathway.
📝 Essential Points
- Metabolic Pathway in Liver: Fructose is rapidly phosphorylated by fructokinase to fructose-1-phosphate, bypassing the main regulatory step of glycolysis.
- Entry into Glycolysis: Fructose-1-phosphate is cleaved by aldolase B into DHAP and glyceraldehyde, which are converted into glycolytic intermediates, feeding into energy production.
- Regulation & Disorders:
- Fructokinase activity is unregulated, leading to rapid fructose phosphorylation.
- Hereditary fructose intolerance results from aldolase B deficiency, causing toxic accumulation of fructose-1-phosphate.
- Dietary Impact: Excessive fructose intake may contribute to obesity, insulin resistance, and potentially cancer, due to its lipogenic effects.
- Interaction with Other Pathways: Fructose metabolism supplies substrates for the pentose phosphate pathway and glycerol synthesis, linking carbohydrate and lipid metabolism.
- Clinical Significance: Recognizing genetic conditions like fructokinase deficiency and aldolase B deficiency is crucial for diagnosis and management.
💡 Key Takeaway
Fructose metabolism in the liver bypasses key regulatory steps of glycolysis, which can lead to metabolic disturbances in hereditary conditions and contribute to lipogenesis when consumed excessively, linking it to obesity and metabolic diseases.
📖 8. Pentose Phosphate Pathway
🔑 Key Concepts & Definitions
- Pentose Phosphate Pathway (PPP): A metabolic pathway parallel to glycolysis that generates NADPH and pentoses (5-carbon sugars) for biosynthesis and nucleotide synthesis.
- NADPH: A reduced coenzyme providing reducing power for anabolic reactions, such as fatty acid and steroid synthesis, and for maintaining redox balance.
- Ribose-5-Phosphate: A 5-carbon sugar produced in the PPP used in nucleotide and nucleic acid synthesis.
- Oxidative Phase: The initial phase of PPP where glucose-6-phosphate is oxidized, producing NADPH and ribulose-5-phosphate.
- Non-Oxidative Phase: The reversible phase where sugars are interconverted, allowing the pathway to produce glycolytic intermediates or pentoses as needed.
- Key Enzymes:
- Glucose-6-Phosphate Dehydrogenase (G6PD): Catalyzes the rate-limiting step, producing NADPH.
- 6-Phosphogluconolactonase: Converts 6-phosphoglucono-δ-lactone to 6-phosphogluconate.
- 6-Phosphogluconate Dehydrogenase: Produces NADPH and ribulose-5-phosphate.
- Transketolase and Transaldolase: Enzymes in the non-oxidative phase that transfer carbon units between sugars.
📝 Essential Points
- Function of PPP: Provides NADPH for reductive biosynthesis and maintains cellular redox state; supplies ribose-5-phosphate for nucleotide synthesis.
- Location: Predominantly active in liver, adipose tissue, adrenal cortex, and red blood cells.
- Regulation: G6PD activity is stimulated by NADP+ and inhibited by NADPH; activity increases when cells require NADPH.
- Balance with Glycolysis: The pathway can supply glycolytic intermediates (fructose-6-phosphate and glyceraldehyde-3-phosphate) via non-oxidative reactions, linking it to energy metabolism.
- Clinical Relevance: Deficiency in G6PD causes hemolytic anemia due to decreased NADPH, impairing red blood cell protection against oxidative damage.
💡 Key Takeaway
The Pentose Phosphate Pathway is crucial for cellular biosynthesis and redox balance, providing NADPH and pentoses, and is tightly regulated according to the cell’s metabolic needs, especially in tissues involved in anabolic processes and red blood cell function.
📊 Synthesis Tables
| Feature | Glucose Transporters (GLUTs) | Glucose Phosphorylation Enzymes |
|---|
| Main Function | Facilitate glucose entry into cells via facilitated diffusion | Phosphorylate glucose to G6P, trapping it inside cells and priming for glycolysis |
| Key Isoforms | GLUT1 (high affinity, ubiquitous), GLUT2 (glucose sensor), GLUT3 (high affinity, neurons), GLUT4 (insulin-dependent) | Hexokinase (low Km, feedback-inhibited), Glucokinase (high Km, no feedback inhibition) |
| Tissue Distribution | Brain, erythrocytes, liver, pancreas, muscle, adipose | Liver, pancreas, muscle (hexokinase); liver & pancreas (glucokinase) |
| Regulatory Features | Tissue-specific expression, insulin regulation (GLUT4), Km determines sensitivity | Feedback inhibition (hexokinase), GKRP regulation (glucokinase) |
| Response to Blood Glucose | High affinity tissues respond at low glucose; GLUT2 responds to high glucose | Glucokinase activity increases with rising blood glucose; hexokinase maintains basal phosphorylation |
| Feature | Glycolysis Regulation | Glycolytic Intermediates & Control Points |
|---|
| Main Enzymes | Hexokinase/Glucokinase, PFK1, Pyruvate Kinase | G6P, F6P, F1,6BP, 3PG, PEP |
| Key Regulatory Steps | PFK1 (rate-limiting), Hexokinase/Glucokinase | PFK1 activated by F2,6P, inhibited by ATP/citrate; Pyruvate kinase regulated by phosphorylation |
| Allosteric Effectors | ATP, ADP, AMP, citrate, F2,6P | F2,6P (activates PFK1), ATP (inhibits PFK1), citrate (inhibits PFK1) |
| Regulation by Hormones | Insulin stimulates PFK2 (F2,6P), promoting glycolysis; Glucagon inhibits | - |
| Key Control Point | PFK1 activity modulated by energy status and F2,6P | - |
⚠️ Common Pitfalls & Confusions
- Confusing GLUT isoforms: assuming all GLUTs respond similarly; remember tissue-specific expression and regulation.
- Misunderstanding Km significance: high Km (glucokinase) indicates low affinity; low Km (hexokinase) indicates high affinity.
- Overlooking feedback inhibition: hexokinase is feedback-inhibited by G6P; glucokinase is not.
- Confusing regulation of PFK1: allosteric effectors (ATP, citrate, F2,6P) have opposing effects.
- Assuming glucokinase is active at all glucose levels; it is active mainly at high glucose concentrations.
- Mistaking the role of GKRP: it sequesters glucokinase in the nucleus at low glucose, preventing activity.
- Overgeneralizing glycolytic intermediates: their regulation is context-dependent and involves multiple control points.
- Ignoring hormonal regulation: insulin and glucagon have opposing effects on glycolysis regulation.
- Confusing the energy yield: net 2 ATP per glucose in glycolysis, with NADH production also contributing to ATP in mitochondria.
- Misinterpreting enzyme regulation: allosteric vs. covalent modifications (e.g., phosphorylation of pyruvate kinase).
✅ Exam Checklist
- Describe the function and tissue distribution of GLUT1, GLUT2, GLUT3, and GLUT4.
- Explain how insulin regulates GLUT4 translocation.
- Differentiate between hexokinase and glucokinase regarding Km, tissue distribution, and regulation.
- Outline the regulatory mechanisms controlling PFK1 activity.
- Identify the key regulatory enzymes in glycolysis and their control points.
- Describe the role of fructose-2,6-bisphosphate in glycolytic regulation.
- Explain the significance of glycolytic intermediates such as G6P and F6P.
- Discuss the fate of pyruvate under aerobic and anaerobic conditions.
- Summarize glycerol and fructose metabolism pathways feeding into glycolysis.
- Describe the pentose phosphate pathway's purpose and key products.
- Recognize the regulatory effects of hormones like insulin and glucagon on glycolytic enzymes.
- Understand the role of the pentose phosphate pathway in NADPH production.
- Recall the key steps and regulatory points in glucose metabolism.
Crée tes propres fiches de révision
Importe ton cours et l'IA génère fiches, QCM et flashcards en 30 secondes.
Générateur de fiches